ACTRIMS Forum 2021: Top Expert Interviews

March 21, 2021
Matt Hoffman
Matt Hoffman

Matt Hoffman, Senior Editor for NeurologyLive, has covered medical news for MJH Life Sciences, NeurologyLive’s parent company, since 2017. He hosts the NeurologyLive Mind Moments podcast, as well as Second Opinion on Medical World News. Follow him on Twitter @byMattHoffman or email him at mhoffman@neurologylive.com

NeurologyLive’s coverage of ACTRIMS Forum 2021 featured a number of insightful conversations with leading experts in multiple sclerosis care.

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2021, which ran virtually from February 25-27, featured a plethora of data presentations, including more than 300 posters and a wide variety of sessions, all focused on the central theme of the “The Spectrum of Multiple Sclerosis.”

As has been the case in years past, NeurologyLive provided coverage of these presentations straight from the conference floor, including the latest updates on therapies in clinical development, the assessment of clinical care strategies, the basic and translational science driving the understanding of MS pathogenesis, and the impact that the COVID-19 pandemic has had on patients and physicians.

Here, we highlight some of those interviews that the NeurologyLive team conducted during the conference, covering topics ranging from the use of disease-modifying therapies in early disease, the progressive phase of MS, and novel therapeutic strategies to the data collected in the COViMS registry and the real-world measurement of fatigue.

To view any of the interviews, click the corresponding image.